This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Toulouse, National Institute of Health and Medical Research, Université Paul Sabatier (Toulouse III). Active years: 2019.
Company Filing History:
1 out of 29 
1 out of 1,853 
1 out of 160 
Years Active: 2019
Title: Laurent Cazals: Innovator in Diabetes Treatment
Introduction
Laurent Cazals is a notable inventor based in Toulouse, France. He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on the use of APJ receptor agonists, which have the potential to transform the management of diabetes.
Latest Patents
Cazals holds a patent for a method and pharmaceutical composition aimed at treating diabetes. The patent details the use of an APJ receptor agonist for the treatment or prevention of diabetes. This invention represents a promising advancement in the pharmaceutical approach to managing this chronic condition. He has 1 patent to his name.
Career Highlights
Throughout his career, Laurent Cazals has worked with esteemed institutions such as the Centre Hospitalier Universitaire de Toulouse and the National Institute of Health and Medical Research. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Cazals has collaborated with notable colleagues, including Pierre Gourdy and Philippe Valet. These partnerships have enriched his research and expanded the impact of his work in the medical community.
Conclusion
Laurent Cazals is a pioneering inventor whose work in diabetes treatment showcases the potential of innovative pharmaceutical solutions. His contributions are vital in the ongoing fight against diabetes, and his research continues to inspire advancements in medical science.